Story excerpt provided by Crain’s Cleveland Business.
Written by Chuck Soder.
Few investors are willing to climb down into the pharmaceutical industry’s valley of death. That place where so many experimental drugs go to die.
But a few local companies have had success raising money from a relatively new category of investors. The kind who will gladly endure the many risks associated with developing new drugs — for the sake of their mission.
At least three startup companies in Cleveland, Ohio recently have raised capital from disease foundations.
Click here to read the complete article.
Originally published January 4, 2015.